Abstract:Objective: To quantify metabolism, a physiologically based pharmacokinetic (PBPK) model for a volatile compound can be calibrated with the closed chamber (i.e. vapor uptake) inhalation data. Here, we introduce global optimization as a novel component of the predictive process and use it to illustrate a procedure for metabolic parameter estimation.Materials and methods: Male F344 rats were exposed in vapor uptake chambers to initial concentrations of 100, 500, 1000, and 3000 ppm chloroform. Chamber time-course data from these experiments, in combination with optimization using a chemical-specific PBPK model, were used to estimate Michaelis–Menten metabolic constants. Matlab® simulation software was used to integrate the mass balance equations and to perform the global optimizations using MEIGO (MEtaheuristics for systems biology and bIoinformatics Global Optimization – Version 64 bit, R2016A), a toolbox written for Matlab®. The cost function used the chamber time-course data and least squares to minimize the difference between data and simulation values.Results and discussion: The final values estimated for Vmax (maximum metabolic rate) and Km (affinity constant) were 1.2 mg/h and a range between 0.0005 and 0.6 mg/L, respectively. Also, cost function plots were used to analyze the dose-dependent capacity to estimate Vmax and Km within the experimental range used. Sensitivity analysis was used to assess identifiability for both parameters and show these kinetic data may not be sufficient to identify Km.Conclusion: In summary, this work should help toxicologists interested in optimization techniques understand the overall process employed when calibrating metabolic parameters in a PBPK model with inhalation data.

A New Method for the Estimation of Absorption Rate Constant in Two-compartment Model by Extravascular Administration.

Absorption Barriers in the Rat Intestinal Mucosa: 2. Application of Physiologically Based Mathematical Models to Quantify Mechanisms of Drug Permeation and Metabolism

The Simulation of the Influence of Two-Compartment Model Parameters on the Plasma Drug Concentration and Drug Effect

A method to determine pharmacokinetic parameters based on andante constant-rate intravenous infusion

Pharmacokinetic model for extravascular administration based on uncertain differential equation

Estimating Organ-to-Plasma Ratios in physiologically based PK modeling: a simplified approach for early drug discovery

Comparison of various estimation methods for the parameters of Michaelis-Menten equation based on in vitro elimination kinetic simulation data

Three-Bottle Exponential Decay Infusion: A Novel Intravenous Infusion Strategy for Drugs Which Conform to Three-Compartment Model with Observations on Propofol Kinetics

Bayesian Inference for Kinetic Models of Biotransformation Using A Generalized Rate Equation

Estimating the rate constant from biosensor data via an adaptive variational Bayesian approach

Reinforcement Learning Based Model Selection and Parameter Estimation for Pharmacokinetic Analysis in Drug Selection.

Application of a New Dynamic Model to Predict the in Vitro Intrinsic Clearance of Tolbutamide Using Rat Microsomes Encapsulated in a Fab Hydrogel

Estimation of Binding Constants of Receptors and Ligands by Affinity Capillary Electrophoresis.

A Novel Parameter Estimation Method for Drug Diffusion, Distribution and Clearance in the Rat Brain Extracellular Space

Statistical Analysis of Two-Compartment Pharmacokinetic Models with Drug Non-adherence

Equilibration rate constant, ke0, to determine effect-site concentration for the Masui remimazolam population pharmacokinetic model in general anesthesia patients

Finite dose skin mass balance including the lateral part: comparison between experiment, pharmacokinetic modeling and diffusion models

Pharmacometric characterization of entero-hepatic circulation processes of orally administered formulations of amiodarone under complex binding kinetics

Methods for Non-Compartmental Pharmacokinetic Analysis With Observations Below the Limit of Quantification

Global optimization of the Michaelis–Menten parameters using physiologically-based pharmacokinetic (PBPK) modeling and chloroform vapor uptake data in F344 rats

Efficient model-based bioequivalence testing